AxoGen, Inc.

AXGN Healthcare Medical Devices

AxoGen, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $225.2 million, up 20.2% from fiscal 2024.

Revenue
+26.2%
EPS
+163.2%
Free cash flow
+995.0%
Total debt
−73.1%

Quarter to September 2026, against a year earlier

49.78 1.03 +2.11%
Market cap
$2.9B
P/E
0.0×
Fwd P/E
−129×
Dividend yield
—
F-score
5/9
Altman Z
9.23
Beneish M
−2.73
Dividend safety
n/a

AxoGen, Inc. (AXGN) Operating margin

Alert me on Operating margin

AxoGen, Inc.'s operating margin over the twelve months to 30 September 2026 was −5.17%, down 1.7 percentage points from fiscal 2025 (−3.49%). Over the past ten years it has ranged from −33.9% (fiscal 2015) to −1.75% (fiscal 2024); the current reading is higher than 91% of that period. That is above the Medical Devices industry median of −15.1% and below the Healthcare sector median of 0.00%.

Operating margin, annual

Embed this chart

Annual newest first

Period Operating margin Change (points)
FY2025 −3.49% (1.74)
FY2024 −1.75% 11.75
FY2023 −13.5% 7.94
FY2022 −21.4% (1.48)
FY2021 −20.0% 0.68
FY2020 −20.6% 8.79
FY2019 −29.4% (5.01)
FY2018 −24.4% (11.26)
FY2017 −13.2% 6.62
FY2016 −19.8% 14.13

Quarterly newest first

Period Operating margin Change (points)
Sep 2026 1.26% 4.35
Jun 2026 −3.09% 1.52
Mar 2026 −4.61% 11.70
Dec 2025 −16.3% (19.49)
43 more quarters

Against its own ten years

Low −33.9% High −1.75%
Ten-year median −20.0%
Current reading's percentile 81

Operating margin against peers

What Operating margin is

EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.

EBIT ÷ Revenue

The full definition of Operating margin →

More on AXGN